Artwork

Content provided by NB Medical Education. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NB Medical Education or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

S4 E2: Gestational Diabetes, CVD risk & modifiable factors; roflumilast for psoriasis; bronchodilators for non-COPD smoking symptoms

20:01
 
Share
 

Manage episode 342675922 series 2558226
Content provided by NB Medical Education. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NB Medical Education or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome to the new Hot Topics podcast from NB Medical with Dr Neal Tucker. After a whirlwind week where general practice has been populistically politicised on all sides, in this episode we stay on safer ground and look at new research.
The BMJ highlights the future risk of cardio- and cerebrovascular disease after gestational diabetes, even without overt diabetes, but offers some good news regarding the optimisation of risk factors. JAMA introduces roflumilast for chronic psoriasis, as a cream, not a tablet. And the NEJM explores whether there is a role for bronchodilators in people with COPD who don't have COPD - symptomatic smokers with preserved lung function.
References
Best research title of the podcast award
BMJ GDM and CVD risk
BMJ GDM and modifiable risk factors
JAMA Roflumilast for psoriasis
NEJM Bronchodilators for smoking Sx with preserved lung function

www.nbmedical.com/podcast

  continue reading

82 episodes

Artwork
iconShare
 
Manage episode 342675922 series 2558226
Content provided by NB Medical Education. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NB Medical Education or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Welcome to the new Hot Topics podcast from NB Medical with Dr Neal Tucker. After a whirlwind week where general practice has been populistically politicised on all sides, in this episode we stay on safer ground and look at new research.
The BMJ highlights the future risk of cardio- and cerebrovascular disease after gestational diabetes, even without overt diabetes, but offers some good news regarding the optimisation of risk factors. JAMA introduces roflumilast for chronic psoriasis, as a cream, not a tablet. And the NEJM explores whether there is a role for bronchodilators in people with COPD who don't have COPD - symptomatic smokers with preserved lung function.
References
Best research title of the podcast award
BMJ GDM and CVD risk
BMJ GDM and modifiable risk factors
JAMA Roflumilast for psoriasis
NEJM Bronchodilators for smoking Sx with preserved lung function

www.nbmedical.com/podcast

  continue reading

82 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide